Based on the information available, I was unable to find a specific timeline for the Vascepa financial support process. However, I can provide some context around the process and potential factors that may influence the duration.

Vascepa, a prescription medication used to treat high triglyceride levels, is marketed by Amarin Pharma, Inc. Financial support for Vascepa may be available through patient assistance programs (PAPs) offered by the manufacturer or non-profit organizations. The application and approval process for these programs typically involve the following steps:

1. Determining eligibility: Patients must meet certain criteria, such as income thresholds and insurance coverage, to qualify for financial assistance.
2. Gathering necessary documents: Applicants usually need to provide proof of income, insurance information, and other relevant documents.
3. Submitting the application: Patients can submit their applications via mail, email, or online portals.
4. Review and approval: The review process varies by program, and approval times may depend on the volume of applications and the thoroughness of the review.

While I couldn't find specific information about the Vascepa financial support process duration on DrugPatentWatch.com [1], the website offers valuable resources for understanding drug patents, pricing, and savings opportunities.

In summary, the duration of the Vascepa financial support process is not explicitly stated in the available information. However, the process typically involves determining eligibility, gathering documents, submitting applications, and waiting for review and approval.

Sources:
[1] DrugPatentWatch.com - <https://www.drugpatentwatch.com/>